3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
9
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Wilms Tumor
1
Stomach Neoplasms
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hepatic Veno-Occlusive Disease
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
7
Therapeutics
6
Flow Cytometry
6
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Filgrastim
4
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Paclitaxel
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Doxorubicin
3
Carboplatin
3
Amplified Fragment Length Polymorphism Analysis
3
venetoclax
2
trametinib
2
temsirolimus
2
sargramostim
2
ruxolitinib
2
pertuzumab
2
pembrolizumab
2
palbociclib
2
liposomal doxorubicin
2
liposomal amphotericin B
2
dabrafenib
2
copanlisib
2
bosutinib
2
aldesleukin
2
abiraterone
2
Vorinostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Hematologic Tests
×
Other hematologic neoplasm
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled